We found that TRPM8 over-expression was observed in 77.8% of the ERα positive tumours and in 37.5% of the ERα negative tumours (p < 0.05, Table 1), suggesting an association between TRPM8 expression and ER+ status. Here, TRPM8 is linked to neoplasm.